Black Seeds (Nigella sativa)

Pharmacological and Therapeutic Applications

1st Edition - September 23, 2021
Editors: Andleeb Khan, Muneeb U Rehman
Language: English
Paperback ISBN:
9 7 8 - 0 - 1 2 - 8 2 4 4 6 2 - 3
eBook ISBN:
9 7 8 - 0 - 3 2 3 - 8 5 9 2 9 - 5

Black Seeds (Nigella sativa) is a comprehensive resource covering all aspects of this medicinal plant, well-known for its positive effects in many human ailments. It has been used… Read more

Purchase options

LIMITED OFFER

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code is needed.

Institutional subscription on ScienceDirect

Request a sales quote

Black Seeds (Nigella sativa) is a comprehensive resource covering all aspects of this medicinal plant, well-known for its positive effects in many human ailments. It has been used to promote health and fight diseases, and has been found to have antioxidant, antihypertensive, anti-diabetic, anti-inflammatory, and analgesic effects. It has also been known to have antimicrobial, anticancer, neuro-protectant, cardio protectant, immunomodulator, hepatic protectant characteristics. Thymoquinone, the active compound of the plant, also exhibits these protective qualities against many disorders. This book summarizes the effect of this plant on all the organ systems of the body. Black Seeds (Nigella sativa) is a comprehensive resource for researchers working in pharmacology, food chemistry and pharmaceutical chemistry, both in industry and academia.

Andleeb Khan

Andleeb Khan (Ph.D.) is Assistant Professor at Jazan University, Saudi Arabia. She has completed her doctorate from Jamia Hamdard, New Delhi, India in Toxicology with specialization in natural and active constituents from plants for prevention of Alzheimer’s Disease. She has teaching and research experience of more than ten years in neurodegenerative disorders and their prevention with medicinal plants, their active principles and nanoformulations. She has published her research in national and international journals and contributed many book chapters with international publishers including Springer Nature and Elsevier. Currently, Dr. Khan is engaged in studying the molecular mechanism of Azheimer’s disease, Ischemic stroke, Parkinson’s Disease and their prevention by various active principles from natural sources and nanoformulations.

Affiliations and expertise

Assistant Professor, Jazan University, Saudi Arabia

Muneeb U Rehman

Muneeb U Rehman (Ph.D.) is a Faculty member at College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. He holds a doctorate in Toxicology (specialization in cancer biology and natural product research) from Jamia Hamdard, New Delhi, India. Dr. Rehman has more than 10 years of research and teaching experience in the field of toxicology, cancer biology, natural product pharmacology and pharmacogenomics. He is the recipient of several national and international fellowships and awards. He has published more than 100 research papers in peer-reviewed, international journals, and has 5 edited books and 30 book chapters. Dr. Rehman is on the editorial boards and is a reviewer of several high-impact, international scientific journals. He is also a life member of various international societies and organizations. Currently, Dr. Rehman is engaged in studying the molecular mechanisms of cancer prevention by natural products and the role of pharmacogenomics and toxicogenomics in evaluating the effectiveness and safety of drugs.

Affiliations and expertise

College of Pharmacy, King Saud University, Riyadh, Saudi Arabia